EMR vs GEV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 29, 2026

EMR

58.4
AI Score
VS
GEV Wins

GEV

61.9
AI Score

Investment Advisor Scores

EMR

58score
Recommendation
HOLD

GEV

62score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric EMR GEV Winner
Forward P/E 21.4592 38.7597 EMR
PEG Ratio 1.7818 1.8622 EMR
Revenue Growth 7.0% 21.9% GEV
Earnings Growth 23.0% 32.8% GEV
Tradestie Score 58.4/100 61.9/100 GEV
Profit Margin 13.8% 23.0% GEV
Beta 1.00 1.00 Tie
AI Recommendation HOLD STRONG BUY GEV

Relative Price Performance (Last 90 Days)

EMR 1M: +7.4% · 3M: +14.1% GEV 1M: +9.1% · 3M: -11.9%

Current Technical Phase

EMR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.5% over 20 days), RSI 59

RSI (14): 58.8 · Price: $158.59

GEV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 56

RSI (14): 56.3 · Price: $980.72

Fundamentals Snapshot

Metric EMR GEV
Market Cap — —
Forward P/E 21.8 39.8
Trailing P/E 34.4 27.3
Revenue (TTM) — —
Revenue Growth 0.1% 0.2%
Gross Margin 0.5% 0.2%
Operating Margin 0.3% 0.1%
EPS 4.51 34.84
Dividend Yield 0.01% 0.00%

Frequently Asked Questions

Based on our detailed analysis, GEV is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.